Skip to main content
. 2010 Dec 22;38(1):408–419. doi: 10.1118/1.3515864

Table 3.

Organ and effective dose of the two patients from their CT examinations. Each patient underwent a combined chest-abdomen-pelvis (CAP) examination consisting of a chest scan and an abdomen-pelvis scan. Each dose value is the average over six tube starting angles. The percentage value in the bracket is the coefficient of variation (standard deviation×100%∕average) across tube starting angles.

  Dose (mGy) Dose ratiob
Newborn (5 weeks, female) Teenager (12 years, male)
Chest Abdomen-pelvis CAPa Chest Abdomen-pelvis CAPa CAP
Respiratory system
Pharynx-larynx 1.86 (5%)c 0.23 (1%) c d, d 2.09 1.03 (17%) c 0.06 (3%) c d, d 1.09 1.9
Trachea-bronchi 3.28 (0%) 0.58 (2%) c d, d 3.86 3.88 (3%) 0.38 (2%) c d, d 4.26 0.9
Lungs 3.68 (0%) 3.54 (3%) 7.22 3.93 (0%) 2.54 (2%) 6.47 1.1
Alimentary system
Esophagus 3.20 (0%) 1.55 (3%) c 4.75 3.35 (2%) 1.37 (1%) 4.72 1.0
Stomach 1.36 (7%) c 6.36 (0%) 7.72 1.53 (17%) c 5.04 (1%) 6.57 1.2
Pancreas 0.34 (2%) c d, d 6.38 (1%) 6.72 0.55 (4%) c d, d 4.91 (1%) 5.46 1.2
Liver 2.02 (8%) c 6.56 (0%) 8.58 1.57 (13%)c 4.93 (0%) 6.50 1.3
Gall bladder 1.02 (16%)c 6.88 (1%) 7.90 0.37 (9%)c d, d 5.52 (8%) 5.89 1.3
Small intestine 0.27 (4%) c 7.07 (0%) 7.34 0.15 (4%)c d, d 5.57 (1%) 5.72 1.3
Large intestine 0.24 (7%) c 6.76 (0%) 7.00 0.10 (3%) c d, d 5.08 (1%) 5.18 1.4
Circulatory system
Heart 3.56 (0%) 4.16 (7%) 7.72 4.14 (1%) 2.61 (10%) 6.75 1.1
Urogenital system
Kidneys 1.52 (8%) c 6.08 (0%) 7.60 0.75 (11%) c 4.52 (0%) 5.27 1.4
Urinary bladder 0.04 (3%) c d, d 6.30 (2%) 6.34 0.02 (2%) c d, d 5.20 (3%) 5.22 1.2
Prostate   -   - - 0.01 (5%) c d, d 4.05 (2%) 4.06 -
Testes   -   - - 0.00 (14%) c d, d 5.10 (15%) 5.10 -
Ovaries 0.05 (5%)c d, d 6.28 (2%) 6.33   -   - - -
Uterus 0.04 (2%) c d, d 6.18 (2%) 6.22   -   - - -
Vagina 0.03 (5%) c d, d 6.24 (2%) 6.27   -   - - -
Skeletal system
Bone surface 1.81 (2%) 3.36 (0%) 5.17 1.45 (1%) 2.68 (0%) 4.13 1.3
Red bone marrow 0.83 (1%) 1.57 (0%) 2.40 1.01 (1%) 1.91 (0%) 2.92 0.8
Integumentary system
Skin 0.54 (1%) 1.70 (1%) 2.24 0.60 (1%) 1.24 (0%) 1.84 1.2
Additional organs∕tissues
Brain 0.12 (1%) c d, d 0.05 (1%) c d, d 0.17 0.07 (2%)c d, d 0.01 (3%) c d, d 0.08 2.1
Eyes 0.08 (7%) c d, d 0.03 (2%) c d, d 0.11 0.05 (3%)c d, d 0.01 (8%) c d, d 0.06 1.8
Thyroid 2.85 (1%) 0.36 (3%) c d, d 3.21 4.47 (10%) 0.23 (2%) c d, d 4.70 0.7
Breasts 2.88 (1%) 1.62 (31%) c 4.50 3.64 (23%) 1.04 (42%) c 4.68 1.0
Thymus 3.53 (0%) 0.73 (3%) c 4.26 4.05 (4%) 0.51 (4%) c d, d 4.56 0.9
Spleen 2.63 (3%) 5.79 (1%) 8.42 1.60 (18%) 4.60 (1%) 6.20 1.4
Adrenal glands 2.04 (2%) 6.05 (0%) 8.09 1.29 (4%)c 4.07 (2%) 5.36 1.5
Residual soft tissues 0.99 (1%) 2.81 (1%) 3.80 0.73 (0%) 1.44 (0%) 2.17 1.8
Effective dose (mSv) 1.64 (1%) 4.04 (2%) 5.68 1.78 (5%) 3.15 (1%) 4.93 1.2
a

Dose from the combined chest-abdomen-pelvis (CAP) examination, i.e., the summation of dose from the chest scan and that from the abdomen-pelvis scan.

b

Dose ratio equals dose to the newborn patient from her CAP examination over dose to the teenager patient from his CAP examination.

c

Organs completely outside of the image coverage (Table 1).

d

Organs completely outside of the scan coverage (scan coverage equals image coverage plus overranging distance, see Table 1).